A multicomponent insulin response sequence mediates a strong repression of mouse glucose-6-phosphatase gene transcription by insulin.

PubWeight™: 1.17‹?› | Rank: Top 10%

🔗 View Article (PMID 9115220)

Published in J Biol Chem on May 02, 1997

Authors

R S Streeper1, C A Svitek, S Chapman, L E Greenbaum, R Taub, R M O'Brien

Author Affiliations

1: Department of Molecular Physiology and Biophysics, Vanderbilt University Medical School, Nashville, Tennessee 37232, USA.

Articles citing this

Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc Natl Acad Sci U S A (2003) 4.34

New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem J (2002) 2.41

The glucose-6-phosphatase system. Biochem J (2002) 1.87

Forkhead transcription factors and cardiovascular biology. Circ Res (2008) 1.28

Identification of a cAMP response element within the glucose- 6-phosphatase hydrolytic subunit gene promoter which is involved in the transcriptional regulation by cAMP and glucocorticoids in H4IIE hepatoma cells. Biochem J (1999) 1.23

Complete normalization of hepatic G6PC deficiency in murine glycogen storage disease type Ia using gene therapy. Mol Ther (2010) 1.21

COP1 functions as a FoxO1 ubiquitin E3 ligase to regulate FoxO1-mediated gene expression. J Biol Chem (2008) 1.16

Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway. J Virol (2011) 1.09

Hepatocyte nuclear factor-4 alpha mediates the stimulatory effect of peroxisome proliferator-activated receptor gamma co-activator-1 alpha (PGC-1 alpha) on glucose-6-phosphatase catalytic subunit gene transcription in H4IIE cells. Biochem J (2003) 1.05

Suppressor of MEK null (SMEK)/protein phosphatase 4 catalytic subunit (PP4C) is a key regulator of hepatic gluconeogenesis. Proc Natl Acad Sci U S A (2010) 0.96

Down-regulation of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by insulin: the role of the forkhead transcription factor FKHRL1. Biochem J (2002) 0.95

Hepatocyte nuclear factor-1 acts as an accessory factor to enhance the inhibitory action of insulin on mouse glucose-6-phosphatase gene transcription. Proc Natl Acad Sci U S A (1998) 0.93

Phorbol ester-induced activation of mitogen-activated protein kinase/extracellular-signal-regulated kinase kinase and extracellular-signal-regulated protein kinase decreases glucose-6-phosphatase gene expression. Biochem J (2001) 0.91

Abdominal obesity and hyperglycemia mask the effect of a common APOC3 haplotype on the risk of myocardial infarction. Am J Clin Nutr (2008) 0.89

Forkhead Box O6 (FoxO6) Depletion Attenuates Hepatic Gluconeogenesis and Protects against Fat-induced Glucose Disorder in Mice. J Biol Chem (2015) 0.83

Pancreatic regulation of glucose homeostasis. Exp Mol Med (2016) 0.81

Akt-induced phosphorylation of N-CoR at serine 1450 contributes to its misfolded conformational dependent loss (MCDL) in acute myeloid leukemia of the M5 subtype. PLoS One (2013) 0.79

Insulin activates RSK (p90 ribosomal S6 kinase) to trigger a new negative feedback loop that regulates insulin signaling for glucose metabolism. J Biol Chem (2013) 0.79

Delineation of the insulin-responsive sequence in the rat cytosolic aspartate aminotransferase gene: binding sites for hepatocyte nuclear factor-3 and nuclear factor I. Biochem J (1999) 0.78

Effect of paraquat-induced oxidative stress on insulin regulation of insulin-like growth factor-binding protein-1 gene expression. J Clin Biochem Nutr (2010) 0.77

Sequence variation between the mouse and human glucose-6-phosphatase catalytic subunit gene promoters results in differential activation by peroxisome proliferator activated receptor gamma coactivator-1alpha. Diabetologia (2008) 0.75

Loss of Interdependent Binding by the FoxO1 and FoxA1/A2 Forkhead Transcription Factors Culminates in Perturbation of Active Chromatin Marks and Binding of Transcriptional Regulators at Insulin-sensitive Genes. J Biol Chem (2016) 0.75

Articles by these authors

Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci U S A (1982) 10.50

The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma. Cell (1983) 8.54

Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science (1996) 6.70

Translocations among antibody genes in human cancer. Science (1983) 6.20

Is the ratio of inhaled corticosteroid to bronchodilator a good indicator of the quality of asthma prescribing? Cross sectional study linking prescribing data to data on admissions. BMJ (1996) 4.05

"Operation Berkshire": the international tobacco companies' conspiracy. BMJ (2000) 4.00

Jellyfish green fluorescent protein as a reporter for virus infections. Plant J (1995) 3.95

Activation and somatic mutation of the translocated c-myc gene in burkitt lymphoma cells. Cell (1984) 3.66

Antibodies to human c-myc oncogene product: evidence of an evolutionarily conserved protein induced during cell proliferation. Science (1984) 3.63

Doctors who smoke. BMJ (1995) 3.26

The ethics of the cash register: taking tobacco research dollars. Tob Control (2001) 3.16

Effects of workplace smoking bans on cigarette consumption. Am J Public Health (1990) 3.08

Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med (1996) 2.94

Chasing Ernst L Wynder: 40 years of Philip Morris' efforts to influence a leading scientist. J Epidemiol Community Health (2003) 2.89

Tobacco industry efforts at discrediting scientific knowledge of environmental tobacco smoke: a review of internal industry documents. J Epidemiol Community Health (2001) 2.86

CCAAT enhancer- binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy. J Clin Invest (1998) 2.74

A David and Goliath story: tobacco advertising and self-regulation in Australia. Br Med J (1980) 2.73

Smoking in public places. BMJ (1996) 2.72

Evaluation of the Sydney "Quit. For Life" anti-smoking campaign. Part 1. Achievement of intermediate goals. Med J Aust (1986) 2.70

Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from patients treated with the protease inhibitor nelfinavir. Antimicrob Agents Chemother (1998) 2.67

Banning smoking outdoors is seldom ethically justifiable. Tob Control (2000) 2.56

Oral acyclovir in the treatment of acute herpes zoster ophthalmicus. Ophthalmology (1986) 2.53

The role of doctors in promoting smoking cessation. BMJ (1993) 2.46

A novel early growth response gene rapidly induced by fibroblast, epithelial cell and lymphocyte mitogens. Oncogene Res (1988) 2.39

Brand preference and advertising recall in adolescent smokers: some implications for health promotion. Am J Public Health (1982) 2.36

General practitioner anti-smoking programmes: which one? Med J Aust (1990) 2.34

Rapid induction in regenerating liver of RL/IF-1 (an I kappa B that inhibits NF-kappa B, RelB-p50, and c-Rel-p50) and PHF, a novel kappa B site-binding complex. Mol Cell Biol (1992) 2.27

"Smoking is a major cause of blindness". Med J Aust (1999) 2.27

Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology (2000) 2.24

Rapid activation of the Stat3 transcription complex in liver regeneration. Hepatology (1995) 2.17

Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. J Biol Chem (2001) 2.09

Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. BMJ (1996) 2.04

Open source marketing: Camel cigarette brand marketing in the "Web 2.0" world. Tob Control (2009) 2.00

Molecular analysis of a resistance-breaking strain of potato virus X. Virology (1992) 1.96

PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth. Mol Cell Biol (1994) 1.95

Health promoting schools and health promotion in schools: two systematic reviews. Health Technol Assess (1999) 1.93

Eyes on the prize: transnational tobacco companies in China 1976-1997. Tob Control (2000) 1.86

An attempt to swindle nature: press anti-immunisation reportage 1993-1997. Aust N Z J Public Health (1998) 1.85

Trapped antihydrogen. Nature (2010) 1.85

Conservation of an insulin response unit between mouse and human glucose-6-phosphatase catalytic subunit gene promoters: transcription factor FKHR binds the insulin response sequence. Diabetes (1999) 1.84

Tobacco in the news: an analysis of newspaper coverage of tobacco issues in Australia, 2001. Tob Control (2003) 1.84

The tobacco industry's accounts of refining indirect tobacco advertising in Malaysia. Tob Control (2004) 1.83

The immediate-early growth response in regenerating liver and insulin-stimulated H-35 cells: comparison with serum-stimulated 3T3 cells and identification of 41 novel immediate-early genes. Mol Cell Biol (1991) 1.82

Stop-smoking clinics: a case for their abandonment. Lancet (1985) 1.81

Identification of LRF-1, a leucine-zipper protein that is rapidly and highly induced in regenerating liver. Proc Natl Acad Sci U S A (1991) 1.78

A variant translocation places the lambda immunoglobulin genes 3' to the c-myc oncogene in Burkitt's lymphoma. Nature (1984) 1.75

Antivaccination activists on the world wide web. Arch Dis Child (2002) 1.74

A novel alteration in the structure of an activated c-myc gene in a variant t(2;8) Burkitt lymphoma. Cell (1984) 1.74

The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice. Virology (1993) 1.74

Children's lives or garden aesthetics? A case study in public health advocacy. Aust J Public Health (1994) 1.70

Focus group composition: a comparison between natural and constructed groups. Aust N Z J Public Health (2001) 1.68

Trends in antibiotic prescribing and associated indications in primary care from 1993 to 1997. J Public Health Med (2001) 1.68

A mire of highly subjective and ineffective voluntary guidelines: tobacco industry efforts to thwart tobacco control in Malaysia. Tob Control (2004) 1.67

Interactions among LRF-1, JunB, c-Jun, and c-Fos define a regulatory program in the G1 phase of liver regeneration. Mol Cell Biol (1992) 1.64

Clinical significance of antenatal calyceal dilatation detected by ultrasound. Lancet (1990) 1.64

Localization of the beta-globin gene by chromosomal in situ hybridization. Am J Hum Genet (1984) 1.64

Rapid activation of post-hepatectomy factor/nuclear factor kappa B in hepatocytes, a primary response in the regenerating liver. J Biol Chem (1994) 1.64

Immunogenicity of peptides derived from a fibronectin-binding protein of S. aureus expressed on two different plant viruses. Vaccine (1999) 1.63

Gone viral? Heard the buzz? A guide for public health practitioners and researchers on how Web 2.0 can subvert advertising restrictions and spread health information. J Epidemiol Community Health (2008) 1.63

Assembly and movement of a plant virus carrying a green fluorescent protein overcoat. Proc Natl Acad Sci U S A (1996) 1.62

Smokers' understandings of cigarette yield labels. Med J Aust (1986) 1.54

Novel delayed-early and highly insulin-induced growth response genes. Identification of HRS, a potential regulator of alternative pre-mRNA splicing. J Biol Chem (1993) 1.53

Behavior therapy and pharmacotherapy for obesity. Arch Gen Psychiatry (1981) 1.51

Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver. EMBO J (1998) 1.50

A preliminary evaluation of nelfinavir mesylate, an inhibitor of human immunodeficiency virus (HIV)-1 protease, to treat HIV infection. J Infect Dis (1998) 1.50

"The world's most hostile environment": how the tobacco industry circumvented Singapore's advertising ban. Tob Control (2004) 1.49

A retinoic acid response element is part of a pleiotropic domain in the phosphoenolpyruvate carboxykinase gene. Proc Natl Acad Sci U S A (1991) 1.48

Do pharmacy staff recommend evidenced-based smoking cessation products? A pseudo patron study. J Clin Pharm Ther (2006) 1.46

Effects of flecainide in patients with new SCN5A mutation: mutation-specific therapy for long-QT syndrome? Circulation (2000) 1.46

The insulin receptor tyrosyl kinase phosphorylates holomeric forms of the guanine nucleotide regulatory proteins Gi and Go. FEBS Lett (1987) 1.46

Immediate-early gene expression differs between regenerating liver, insulin-stimulated H-35 cells, and mitogen-stimulated Balb/c 3T3 cells. Liver-specific induction patterns of gene 33, phosphoenolpyruvate carboxykinase, and the jun, fos, and egr families. J Biol Chem (1990) 1.45

A prospective analysis of 211 robotic-assisted surgical procedures. Surg Endosc (2003) 1.44

Changes in acceptance of workplace smoking bans following their implementation: a prospective study. Prev Med (1990) 1.44

Phosphatidylinositol 3-kinase, but not p70/p85 ribosomal S6 protein kinase, is required for the regulation of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by insulin. Dissociation of signaling pathways for insulin and phorbol ester regulation of PEPCK gene expression. J Biol Chem (1995) 1.43

Transcriptional regulatory signals define cytokine-dependent and -independent pathways in liver regeneration. Semin Liver Dis (1999) 1.41

Smoke and letters. JAMA (1994) 1.40

Industry sponsored youth smoking prevention programme in Malaysia: a case study in duplicity. Tob Control (2004) 1.40

Predictors of optimal virological response to potent antiretroviral therapy. AIDS (1999) 1.40

Australian surgeons savaged by cutting report. BMJ (1994) 1.39

Molecular cloning of a pancreatic islet-specific glucose-6-phosphatase catalytic subunit-related protein. Diabetes (1999) 1.39

The limitations of econometric analysis in cigarette advertising studies. Br J Addict (1989) 1.38

Autoresonant excitation of antiproton plasmas. Phys Rev Lett (2011) 1.38

Postmodernism and public health. Aust N Z J Public Health (1998) 1.37

Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury. Mol Cell Biol (2001) 1.37

Insulin as a growth factor in rat hepatoma cells. Stimulation of proto-oncogene expression. J Biol Chem (1987) 1.36

Staff members' acceptance of the introduction of workplace smoking bans in the Australian public service. Med J Aust (1989) 1.36

HRS/SRp40-mediated inclusion of the fibronectin EIIIB exon, a possible cause of increased EIIIB expression in proliferating liver. Mol Cell Biol (1997) 1.35

High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes. J Clin Invest (1995) 1.33

Induction patterns of 70 genes during nine days after hepatectomy define the temporal course of liver regeneration. J Clin Invest (1993) 1.32

The Philippine tobacco industry: "the strongest tobacco lobby in Asia". Tob Control (2004) 1.31

The news on tobacco control: time to bring the background into the foreground. Tob Control (1999) 1.30

Smoking in movies: is it a problem? Tob Control (1997) 1.29

Cloning and characterization of the human and rat islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) genes. J Biol Chem (2001) 1.28

Research from tobacco industry affiliated authors: need for particular vigilance. Tob Control (2005) 1.27